The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
Open accessAbstract
Objectives COVID-19 has been arguably the most important public health concern worldwide in 2020, and efforts are now escalating to suppress or eliminate its spread. In this study we undertook a meta-analysis to estimate the global and regional seroprevalence rates in humans of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and to assess whether seroprevalence is associated with geographical, climatic and/or sociodemographic factors. Methods We systematically reviewed PubMed, Scopus, Embase, medRxiv and bioRxiv databases for preprints or peer-reviewed articles (up to 14 August 2020). Study eligibility criteria were population-based studies describing the prevalence of anti-SARS-CoV-2 (IgG and/or IgM) serum antibodies. Participants were people from different socioeconomic and ethnic backgrounds (from the general population), whose prior COVID-19 status was unknown and who were tested for the presence of anti-SARS-CoV-2 serum antibodies. We used a random-effects model to estimate pooled seroprevalence, and then extrapolated the findings to the global population (for 2020). Subgroup and meta-regression analyses explored potential sources of heterogeneity in the data, and relationships between seroprevalence and sociodemographic, geographical and/or climatic factors. Results In total, 47 studies involving 399 265 people from 23 countries met the inclusion criteria. Heterogeneity (I2 = 99.4%, p < 0.001) was seen among studies; SARS-CoV-2 seroprevalence in the general population varied from 0.37% to 22.1%, with a pooled estimate of 3.38% (95%CI 3.05–3.72%; 15 879/399 265). On a regional level, seroprevalence varied from 1.45% (0.95–1.94%, South America) to 5.27% (3.97–6.57%, Northern Europe), although some variation appeared to relate to the serological assay used. The findings suggested an association of seroprevalence with income levels, human development indices, geographic latitudes and/or climate. Extrapolating to the 2020 world population, we estimated that 263.5 million individuals had been exposed or infected at the time of this study. Conclusions This study showed that SARS-CoV-2 seroprevalence varied markedly among geographic regions, as might be expected early in a pandemic. Longitudinal surveys to continually monitor seroprevalence around the globe will be critical to support prevention and control efforts, and might indicate levels of endemic stability or instability in particular countries and regions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 1×
“Coronavirus 19 disease (COVID-19)da severe, acute respiratory syndrome caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)dwas first identified in Wuhan, China, in December2019 [1,2], andspreadwithinmonths tomostnationsof the world [3].”
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Tao, Q., Sun, Z., & Xia, L. (2020) · Radiology · doi:10.1148/radiol.2020200642 · Cited by 5,685
Chu, D. K., Akl, E. A., Duda, S., Solo, K., Yaacoub, S., Schünemann, H. J., Chu, D. K., Akl, E. A., El-harakeh, A., Bognanni, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31142-9 · Cited by 3,843 · cited 1×
“A global metaanalysis [74] showed that applying physical distancing of 1 m and usage of personal protective equipment (PPE, including face mask, eye and body protection) results in a major reduction in transmission/infection risk.”
BackgroundHow will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Methods to estimate the between‐study variance and its uncertainty in meta‐analysis
Veroniki, A. A., Jackson, D., Viechtbauer, W., Bender, R., Bowden, J., Knapp, G., Kuss, O., Higgins, J. P., Langan, D., & Salanti, G. (2016) · Research Synthesis Methods · doi:10.1002/jrsm.1164 · Cited by 1,685
Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature
Lowen, A. C., Mubareka, S., Steel, J., & Palese, P. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030151 · Cited by 1,669
Hospitalization and mortality among Black patients and White patients with Covid-19.
Price-Haywood, E. G., Burton, J., Fort, D., & Seoane, L. (2020) · New England Journal of Medicine · doi:10.1056/nejmsa2011686 · Cited by 1,660
Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo, J., Hernán, M. A., Pérez-Olmeda, M., Sanmartín, J. L., Fernández-García, A., Cruz, I., Fernández de Larrea, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31483-5 · Cited by 1,639
Coronavirus disease 2019 case surveillance—United States, January 22–May 30, 2020.
Stokes, E. K., Zambrano, L. D., Anderson, K. N., Marder, E. P., Raz, K. M., El Burai Felix, S., Tie, Y., & Fullerton, K. E. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6924e2 · Cited by 1,538
Interpreting Diagnostic Tests for SARS-CoV-2
Sethuraman, N., Jeremiah, S. S., & Ryo, A. (2020) · JAMA · doi:10.1001/jama.2020.8259 · Cited by 1,494
Munn, Z., Moola, S., Riitano, D., & Lisy, K. (2014) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2014.71 · Cited by 1,479 · cited 1×
“The quality of studies included in the meta-analysis was assessed using the Joanna Briggs Institute (JBI) Prevalence Critical Appraisal Tool [34].”
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
Munster, V. J., Koopmans, M., van Doremalen, N., van Riel, D., & de Wit, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2000929 · Cited by 1,415
United Nations Development Program
(2006) · Encyclopedia of World Poverty · doi:10.4135/9781412939607.n718 · Cited by 1,301
Real estimates of mortality following COVID-19 infection
Baud, D., Qi, X., Nielsen-Saines, K., Musso, D., Pomar, L., & Favre, G. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30195-x · Cited by 1,253
Assessing differential impacts of COVID-19 on black communities
Millett, G. A., Jones, A. T., Benkeser, D., Baral, S., Mercer, L., Beyrer, C., Honermann, B., Lankiewicz, E., Mena, L., Crowley, J. S., et al. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.05.003 · Cited by 1,217
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Huang, A. T., Garcia-Carreras, B., Hitchings, M. D. T., Yang, B., Katzelnick, L. C., Rattigan, S. M., Borgert, B. A., Moreno, C. A., Solomon, B. D., Trimmer-Smith, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18450-4 · Cited by 1,026
Stringhini, S., Wisniak, A., Piumatti, G., Azman, A. S., Lauer, S. A., Baysson, H., De Ridder, D., Petrovic, D., Schrempft, S., Marcus, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31304-0 · Cited by 990
Harbord, R. M., & Higgins, J. P. T. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800403 · Cited by 897 · cited 6×
“To assess the effect of these variables on seroprevalence, we carried out random effects meta-regression analyses using the ‘metareg’ command in Stata [37].”
InfluentialChan, J. F.-W., Yip, C. C.-Y., To, K. K.-W., Tang, T. H.-C., Wong, S. C.-Y., Leung, K.-H., Fung, A. Y.-F., Ng, A. C.-K., Zou, Z., Tsoi, H.-W., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00310-20 · Cited by 880
Antibody tests for identification of current and past infection with SARS‐CoV‐2
Geppert, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., Bergman, H., Buckley, S. B., et al. (2022) · LSTM Online Archive (Liverpool School of Tropical Medicine) · Cited by 850
Self-citationNeutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.007 · Cited by 847
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
Lisboa Bastos, M., Tavaziva, G., Abidi, S. K., Campbell, J. R., Haraoui, L.-P., Johnston, J. C., Lan, Z., Law, S., MacLean, E., Trajman, A., et al. (2020) · BMJ · doi:10.1136/bmj.m2516 · Cited by 832
Hunter, J. P., Saratzis, A., Sutton, A. J., Boucher, R. H., Sayers, R. D., & Bown, M. J. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.03.003 · Cited by 786 · cited 1×
“As publication bias is not relevant for prevalence studies [38], it was not assessed.”
Otter, J. A., Donskey, C., Yezli, S., Douthwaite, S., Goldenberg, S. D., & Weber, D. J. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.08.027 · Cited by 780
Effects of Air Temperature and Relative Humidity on Coronavirus Survival on Surfaces
Casanova, L. M., Jeon, S., Rutala, W. A., Weber, D. J., & Sobsey, M. D. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02291-09 · Cited by 735
Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., Yanny, I., Razavi, H., & Vickerman, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00485-5 · Cited by 731
Antibody tests for identification of current and past infection with SARS-CoV-2
Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C., Spijker, R., Taylor-Phillips, S., Adriano, A., Beese, S., Dretzke, J., Ferrante di Ruffano, L., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013652 · Cited by 655
Self-citationSeroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020
Havers, F. P., Reed, C., Lim, T., Montgomery, J. M., Klena, J. D., Hall, A. J., Fry, A. M., Cannon, D. L., Chiang, C.-F., Gibbons, A., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.4130 · Cited by 647
van Doremalen, N., Bushmaker, T., & Munster, V. J. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.38.20590 · Cited by 582
Sajadi, M. M., Habibzadeh, P., Vintzileos, A., Shokouhi, S., Miralles-Wilhelm, F., & Amoroso, A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.11834 · Cited by 566
Correlation between universal BCG vaccination policy and reduced mortality for COVID-19
Miller, A., Reandelar, M. J., Fasciglione, K., Roumenova, V., Li, Y., & Otazu, G. H. (2020) · medRxiv · doi:10.1101/2020.03.24.20042937 · Cited by 506
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
Xu, X., Sun, J., Nie, S., Li, H., Kong, Y., Liang, M., Hou, J., Huang, X., Li, D., Ma, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0949-6 · Cited by 405
Killerby, M. E., Link-Gelles, R., Haight, S. C., Schrodt, C. A., England, L., Gomes, D. J., Shamout, M., Pettrone, K., O'Laughlin, K., Kimball, A., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6925e1 · Cited by 357
Low ambient humidity impairs barrier function and innate resistance against influenza infection
Kudo, E., Song, E., Yockey, L. J., Rakib, T., Wong, P. W., Homer, R. J., & Iwasaki, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902840116 · Cited by 341
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
Ward, H., Atchison, C., Whitaker, M., Ainslie, K. E. C., Elliott, J., Okell, L., Redd, R., Ashby, D., Donnelly, C. A., Barclay, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21237-w · Cited by 337
Schaffer, F. L., Soergel, M. E., & Straube, D. C. (1976) · Archives of Virology · doi:10.1007/bf01317930 · Cited by 302
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
Kontou, P. I., Braliou, G. G., Dimou, N. L., Nikolopoulos, G., & Bagos, P. G. (2020) · Diagnostics · doi:10.3390/diagnostics10050319 · Cited by 288
Montesinos, I., Gruson, D., Kabamba, B., Dahma, H., Van den Wijngaert, S., Reza, S., Carbone, V., Vandenberg, O., Gulbis, B., Wolff, F., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104413 · Cited by 271
Dynamics of Airborne Influenza A Viruses Indoors and Dependence on Humidity
Yang, W., & Marr, L. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021481 · Cited by 263
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Rosenberg, E. S., Tesoriero, J. M., Rosenthal, E. M., Chung, R., Barranco, M. A., Styer, L. M., Parker, M. M., John Leung, S.-Y., Morne, J. E., Greene, D., et al. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.06.004 · Cited by 262
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
Lee, C. Y.-P., Lin, R. T. P., Renia, L., & Ng, L. F. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00879 · Cited by 260
Van Elslande, J., Houben, E., Depypere, M., Brackenier, A., Desmet, S., André, E., Van Ranst, M., Lagrou, K., & Vermeersch, P. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.05.023 · Cited by 252
Barreca, A. I., & Shimshack, J. P. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws259 · Cited by 236
Kwatra, G., Cunnington, M. C., Merrall, E., Adrian, P. V., Ip, M., Klugman, K. P., Tam, W. H., & Madhi, S. A. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30055-x · Cited by 234
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.04.008 · Cited by 199
Percivalle, E., Cambiè, G., Cassaniti, I., Nepita, E. V., Maserati, R., Ferrari, A., Di Martino, R., Isernia, P., Mojoli, F., Bruno, R., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.24.2001031 · Cited by 171
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
Shakiba, M., Nazemipour, M., Salari, A., Mehrabian, F., Nazari, S. S. H., Rezvani, S. M., Ghasempour, Z., Heidarzadeh, A., & Mansournia, M. A. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2702.201960 · Cited by 164
Ward, H., Atchison, C. J., Whitaker, M. D., et al. (2020) · medRxiv · doi:10.1101/2020.08.12.20173690v2 · Cited by 155
Novel Coronavirus and Old Lessons — Preparing the Health System for the Pandemic
Hick, J. L., & Biddinger, P. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005118 · Cited by 151
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors
Gallian, P., Pastorino, B. A. M., Morel, P., Chiaroni, J., Ninove, L., & de Lamballerie, X. N. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104880 · Cited by 138
Rosado, J., Pelleau, S., Cockram, C. A., Merkling, S. H., Nekkab, N., Demeret, C., Meola, A., Kernéis, S., Terrier, B., Fafi‐Kremer, S., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30197-x · Cited by 132
Fischer, B., Knabbe, C., & Vollmer, T. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.28.2001285 · Cited by 88
Hallal, P. C., Hartwig, F. P., Horta, B. L., Victora, G. D., da Silveira, M. F., Struchiner, C. J., Vidaletti, L. P., Neumann, N. A., Pellanda, L. C., Dellagostin, O. A., et al. (2020) · medRxiv · doi:10.1101/2020.05.30.20117531 · Cited by 86
Modi, C., Böhm, V., Ferraro, S., Stein, G., & Seljak, U. (2020) · medRxiv · doi:10.1101/2020.04.15.20067074 · Cited by 72
The Prevalence of Antibodies to SARS-CoV-2 Among Blood Donors in China
Chang, L., Hou, W., Zhao, L., Zhang, Y., Wang, Y., Wu, L., Xu, T., Wang, L., Wang, J., Ma, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-021-21503-x · Cited by 71
Caini, S., Bellerba, F., Corso, F., Díaz‐Basabe, A., Natoli, G., Paget, J., Facciotti, F., Angelis, S. P. D., Raimondi, S., Palli, D., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.23.2000980 · Cited by 65
Wolff, F., Dahma, H., Duterme, C., den Wijngaert, S. V., Vandenberg, O., COTTON, F. J., & Montesinos, I. (2020) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2020.115140 · Cited by 60
Żuk, T., Rakowski, F., & Radomski, J. P. (2009) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2009.07.005 · Cited by 27
Low postpandemic wave SARS‐CoV‐2 seroprevalence in Kuala Lumpur and Selangor, Malaysia
Sam, I., Chong, Y. M., Tan, C. W., & Chan, Y. F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26426 · Cited by 22
Thomas, S. N., Altawallbeh, G., Zaun, C. P., Pape, K. A., Peters, J. M., Titcombe, P. J., Dileepan, T., Rapp, M. J., Bold, T. D., Schacker, T. W., et al. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.01.010 · Cited by 21
Poverty and the Impact of COVID-19
Hotez, P. J. (2020) · Johns Hopkins University Press eBooks · doi:10.1353/book.75688 · Cited by 7
Self-citation
Cited by
Hansen, C. H., Michlmayr, D., Gubbels, S. M., Mølbak, K., & Ethelberg, S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00575-4 · Cited by 586
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Chen, X., Chen, Z., Azman, A. S., Deng, X., Sun, R., Zhao, Z., Zheng, N., Chen, X., Lu, W., Zhuang, T., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00026-7 · Cited by 239
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
Bobrovitz, N., Arora, R. K., Cao, C., Boucher, E., Liu, M., Donnici, C., Yanes-Lane, M., Whelan, M., Perlman-Arrow, S., Chen, J., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252617 · Cited by 246
Singh, S., McNab, C., Olson, R. M., Bristol, N., Nolan, C., Bergstrøm, E., Bartos, M., Mabuchi, S., Panjabi, R., Karan, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01897-3 · Cited by 141
Vial, P., González, C., Icaza, G., Ramirez-Santana, M., Quezada-Gaete, R., Núñez-Franz, L., Apablaza, M., Vial, C., Rubilar, P., Correa, J., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07045-7 · Cited by 31
Metadata
- Authors
- Rostami, A., Sepidarkish, M., Leeflang, M. M. G., Riahi, S. M., Nourollahpour Shiadeh, M., Esfandyari, S., Mokdad, A. H., Hotez, P. J., & Gasser, R. B.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 27
- Issue
- 3
- Pages
- 331-340
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W3093877663
- Cited by
- 369
- References
- 65
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.